10/28/2008

Siemens opens Cologne research centre

Siemens Healthcare has opened a new research centre in Cologne, where around 40 employees are developing new diagnostic tests to describe the molecular characteristics of breast cancer cells, to help physicians to select individual therapy.

Siemens has also been researching innovative biochips for breast cancer tests. ‘Biochips can perform hundreds and, in extreme cases, hundreds of thousands of diagnostic tests simultaneously. Many different tumour characteristics must be investigated in order to identify the possibility of various therapies,’ the firm points out. ‘Biochips are therefore especially suitable for performing a high number of required tests both fast and efficiently.’
The Siemens ‘Breast Care Solutions’ package combines various imaging techniques including ultrasound, mammography and magnetic resonance imaging, and these are now supplemented by laboratory diagnostic tests and DP based evaluation systems.